PDF下载 ( 153 KB)
Hepatology International｜表达靶向HBV抗原的TCR-T细胞治疗肝移植后复发的肝细胞癌患者具有良好的安全性和可行性：Ⅰ期临床试验结果
DOI: 10.3969/j.issn.1001-5256.2023.10.gwjpwzjj1
Hepatology International｜Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial
本文二维码
计量
- 文章访问数: 252
- HTML全文浏览量: 187
- PDF下载量: 26
- 被引次数: 0
下载:
